CEA Industries ‘applauds’ FDA authorization of JUUL products

CEA Industries (VAPE) issued a statement applauding the U.S. Food and Drug Administration’s (FDA) decision to authorize JUUL e-cigarette products for sale in the United States. The announcement follows the FDA’s reversal of its 2022 federal ban, marking a significant milestone in the evolution of the U.S. nicotine market and underscoring the agency’s recognition of e-cigarettes as a less-harmful alternative for adult cigarette smokers. “We applaud the FDA’s decision to authorize JUUL products for U.S. sale,” said Tony McDonald, CEO. “This milestone represents a critical step toward establishing a regulated and transparent U.S. marketplace for nicotine vape products. We view the FDA’s action as a sign of growing recognition of science-backed alternatives for smokers, and we are optimistic that it will create opportunities for CEA Industries to participate in the U.S. nicotine vape market over the long-term.”